Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review

BACKGROUND: Muscle growth promoters are being developed for the treatment of disease-induced loss of muscle mass. Ligandrol and ostarine are selective androgen receptor modulators (SARMs) with a non-steroidal structure and a presumably more favorable side effect profile. In recent years, these subst...

Descripción completa

Detalles Bibliográficos
Autores principales: Koller, Tomas, Vrbova, Petra, Meciarova, Iveta, Molcan, Pavol, Smitka, Michal, Adamcova Selcanova, Svetlana, Skladany, Lubomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180234/
https://www.ncbi.nlm.nih.gov/pubmed/34141767
http://dx.doi.org/10.12998/wjcc.v9.i16.4062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180234/
https://www.ncbi.nlm.nih.gov/pubmed/34141767
http://dx.doi.org/10.12998/wjcc.v9.i16.4062

Ejemplares similares